VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HTGC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HTGCHercules Capital, Inc.
$15.99$3.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

HTGC logoHercules Capital, Inc.(HTGC)Earnings, Financials & Key Ratios

HTGC•NYSE
$15.99
8.6× P/E·Price updated Jul 7, 2026
SectorFinancial ServicesIndustryAsset ManagementSub-IndustryPrivate credit and BDC lenders
AboutHercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups, to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, development and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest; particularly in the areas of software, biotech and information services. The firm prefers to invest between $10 million to $250 million in equity per transactions. It invests generally between $1 million to $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital. The firm formerly known as Hercules Technology Growth Capital, Inc. Hercules Capital, Inc. was founded in December 2003 and is based in Palo Alto, California with additional offices in Connecticut; Boston, Massachusetts; San Diego, California; Westport, Connecticut; Elmhurst, Illinois; Santa Monica, California; McLean, Virginia; New York, New York; Radnor, Pennsylvania; and Washington, District of Columbia and London, United Kingdom.Show more
  • EBITDA$365M+38.7%
  • Net Income$340M+29.2%
  • EPS (Diluted)1.85+14.9%
  • Gross Margin87.23%+6.3%
  • EBITDA Margin66.81%+9.3%
  • Operating Margin66.75%+9.4%
  • Net Margin62.1%+1.8%
  • ROE16.16%+16.5%

HTGC Price & Volume

Hercules Capital, Inc. (HTGC) stock price & volume — 10-year historical chart

Loading chart...

Venture Debt Volatility Challenges Earnings Quality Sustainability

Investment Thesis • Updated 2026Q1

VerdictNeutral
Growth:Mixed
Profitability:Strong
Financial:Healthy
Cash Flow:Deteriorating
Primary Risk:Venture ecosystem funding volatility

Key Thesis Takeaways

  • Hercules Capital demonstrates significant operating leverage with margins reaching 76.7% in 2023Q4, yet the firm's reliance on venture-backed borrowers creates substantial earnings volatility, as evidenced by the decline in EPS from $0.78 in 2023Q4 to $0.23 in 2026Q1.
  • While the internal management structure avoids external advisory fees, the disconnect between net income and cash flow, highlighted by an OCF/NI ratio of -4.41 in 2025Q1, suggests that dividend sustainability may be increasingly dependent on balance sheet liquidity.
  • Investors should monitor the firm's exposure to Level 3 asset valuations and the potential for credit quality deterioration if the venture capital IPO window remains constrained.

Verdict Logic

while the 9.1% dividend yield is attractive, the significant divergence between earnings and cash flow, evidenced by a negative $230.6 million FCF in 2026Q1, warrants caution regarding long-term distribution coverage.

HTGC Growth Metrics

Hercules Capital, Inc. (HTGC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years15.77%
5 Years8.89%
3 Years31.72%
TTM-

Profit CAGR

10 Years22.99%
5 Years8.37%
3 Years49.3%
TTM30.16%

EPS CAGR

10 Years12.11%
5 Years-1.65%
3 Years32.79%
TTM33.08%

Return on Capital

10 Years7.01%
5 Years7.68%
3 Years9.03%
Last Year8.8%

HTGC Recent Earnings

Hercules Capital, Inc. (HTGC) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 6/12 qtrs (50%)●Beat Revenue 5/12 qtrs (42%)
Q2 2026Latest
May 5, 2026
Metric
Actual
Est
EPS
$0.48+2.1%
$0.47
Rev
$142M+0.1%
$141M
Q1 2026
Feb 12, 2026
Metric
Actual
Est
EPS
$0.48+0.0%
$0.48
Rev
$137M-2.9%
$142M
Q4 2025
Oct 30, 2025
Metric
Actual
Est
EPS
$0.49+2.1%
$0.48
Rev
$169M+19.9%
$141M
Q3 2025
Jul 31, 2025
Metric
Actual
Est
EPS
$0.50+6.4%
$0.47
Rev
$80M-41.3%
$136M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 5, 2026
$0.48vs $0.47+2.1%
$142Mvs $141M+0.1%
Q1 2026Feb 12, 2026
$0.48vs $0.48+0.0%
$137Mvs $142M-2.9%
Q4 2025Oct 30, 2025
$0.49vs $0.48+2.1%
$169Mvs $141M+19.9%
Q3 2025Jul 31, 2025
$0.50vs $0.47+6.4%
$80Mvs $136M-41.3%
Based on last 12 quarters of dataView full earnings history →

Latest HTGC News

Recent stock market news and headlines for Hercules Capital, Inc. (HTGC)

GlobeNewsWire·Jun 29, 2026
4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital

EMERYVILLE, Calif., June 29, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that it has entered into a strategic credit facility agreement with Hercules Capital, Inc. (NYSE: HTGC) (“Hercules”) for up to $200 million.

Zacks Investment Research·Jun 26, 2026
Hercules Capital (HTGC) Advances While Market Declines: Some Information for Investors

In the closing of the recent trading day, Hercules Capital (HTGC) stood at $15.58, denoting a +2.23% move from the preceding trading day.

Zacks Investment Research·Jun 24, 2026
Brokers Suggest Investing in Hercules Capital (HTGC): Read This Before Placing a Bet

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Seeking Alpha·Jun 23, 2026
Hercules Capital: This 12% Yield Is My Top Pick For The Back Half

Hercules Capital stands out among BDCs for its resilient, venture-focused portfolio and minimal AI disruption risk. HTGC maintains strong credit quality, with only 0.1% of its portfolio on non-accrual and a 12% yield, supporting a Strong Buy rating. Portfolio composition is 44% healthcare/life sciences and 35% application software, with high barriers to entry and AI beneficiaries.

Seeking Alpha·Jun 22, 2026
Hercules Capital Faces Its Own 12 Labors

Hercules Capital is trading at a 30% premium to NAV, down from 72% in 2024, reflecting compressed sentiment around technology-focused BDCs. HTGC is paying out a 12.1% dividend yield, with a $0.40 base and a $0.07 supplemental quarterly dividend. The base dividend was 120% covered by first-quarter net investment income. Portfolio credit quality remains robust, with nonaccruals at fair value at just 0.1% of the total investment portfolio as of the end of the first quarter.

Peers Comparison

Key metrics vs top competitors for Hercules Capital, Inc. (HTGC)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
HTGC logoHTGCHercules Capital, Inc.Current
$15.99$2.99B8.6426.97%62.1%16.16%8.86%
ARCC logoARCCAres Capital Corporation
$18.47$13.26B9.9332.87%43.69%8.11%—
GBDC logoGBDCGolub Capital BDC, Inc.
$12.75$3.32B8.9842.5%26.91%5.24%—
OBDC logoOBDCBlue Owl Capital Corporation
$10.83$5.38B8.7352.55%27.51%4.83%—
TPVG logoTPVGTriplePoint Venture Growth BDC Corp.
$4.75$192.85M3.8936.55%-19.55%-3.39%—
GSBD logoGSBDGoldman Sachs BDC, Inc.
$9.00$1.01B8.7426%25.87%5.14%—

Compare HTGC vs Peers

Hercules Capital, Inc. (HTGC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs ARCC

Most directly comparable listed peer for HTGC.

Scale Benchmark

vs ARES

Larger-name benchmark to compare HTGC against a more recognizable public peer.

Peer Set

Compare Top 5

vs ARCC, GBDC, OBDC, TPVG

HTGC SEC Filings & Documents

Hercules Capital, Inc. (HTGC) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 5, 2026·SEC

Material company update

May 4, 2026·SEC

Material company update

Feb 12, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 12, 2026·SEC

FY 2025

Feb 13, 2025·SEC

FY 2024

Feb 15, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 5, 2026·SEC

FY 2025

Oct 30, 2025·SEC

FY 2025

Jul 31, 2025·SEC

Get notified when HTGC posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

HTGC Frequently Asked Questions

Hercules Capital, Inc. (HTGC) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Hercules Capital, Inc.'s revenue?

Hercules Capital, Inc. (HTGC) reported $578.2M in revenue for fiscal year 2025.

How fast is Hercules Capital, Inc. growing?

Hercules Capital, Inc. (HTGC) grew revenue by 27.0% over the past year. This is strong growth.

Is HTGC profitable?

Yes, Hercules Capital, Inc. (HTGC) is profitable, generating $289.4M in net income for fiscal year 2025 (62.1% net margin).

Dividend & Returns
Does HTGC pay dividends?

Yes, Hercules Capital, Inc. (HTGC) pays a dividend with a yield of 8.86%. This makes it attractive for income-focused investors.

What is HTGC's return on equity?

Hercules Capital, Inc. (HTGC) has a return on equity (ROE) of 16.2%. This is reasonable for most industries.

What is Hercules Capital, Inc.'s free cash flow?

Hercules Capital, Inc. (HTGC) had negative free cash flow of $351.7M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in HTGC back in 2004?

Total return calculator · dividends reinvested · 22+ years of data

See returns →